Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01056861 · ClinicalTrials.gov registry record
Effects of Botulinum Toxin in Cervical Dystonia
A clinical trial, sponsored by Henry Ford Health System.
- Completed
- Registry status
- 7
- Enrollment target
NCT01056861: Completed study, sponsored by Henry Ford Health System.
NCT01056861 is a clinical trial that has completed, run by Henry Ford Health System. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01056861 has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
Botulinum toxin injection in the contracting muscles has proven to be a safe and effective method of relieving pain and lessening dystonic posturing. The current hypothesis is that botulinum toxin works on altering sensory input in the central nervous system in addition to its effects on the neuromuscular junction. Magnetoencephalography (MEG)of brain has been used in dystonia such as writer's cramp and musician's hand dystonia. However, no study has investigated the correlation of central signal changes via magnetoencephalography before and after treatment with botulinum in torticollis patients. Prior studies using somatosensory potentials indicated the possibility of differential activation of precentral cortex in patients with cervical dystonia. Cervical dystonia may result from a disorder of both cortical excitability and intracortical inhibition. The investigators hypothesis is that botulinum injection modulates central inhibition which improves clinical outcome for torticollis.
Interventions
- DRUG Botulinum Toxin A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2010-01 |
| Est. Completion | 2014-07 |
What the finished NCT01056861 record still lists
NCT01056861 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Botulinum Toxin A is the first listed.
NCT01056861 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01056861 about?
NCT01056861 is a clinical study titled "Effects of Botulinum Toxin in Cervical Dystonia". Botulinum toxin injection in the contracting muscles has proven to be a safe and effective method of relieving pain and lessening dystonic posturing. The current hypothesis is that botulinum toxin works on altering sensory input in the central nervous system in addition to its effects on the neuromu...
What is the current status of trial NCT01056861?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2010-01. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01056861?
The interventions under investigation include: Botulinum Toxin A (DRUG).
Who is sponsoring clinical trial NCT01056861?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia